Notably, hepcidin inhibition increases the response of mice bearing CT26-derived tumors to PD-1 blockers [62], raising the possibility that reducing hepcidin levels in CRC cells increases the immunogenicity of the tumor microenvironment, converting cold tumors to hot tumors. This evidence concerns the gene HAMP and neoplasm.